10-Q: Neuralbase AI Reports Zero Revenue, Going Concern Doubt
Quarterly Report
Neuralbase AI Ltd. reported no revenue and a significant net loss for the six months ended June 30, 2025, raising substantial doubt about its ability to continue as a going concern.
Summary
- Neuralbase AI Ltd. reported no revenue for the three and six months ended June 30, 2025, and June 30, 2024.
- Net loss for the six months ended June 30, 2025, was $154,667, compared to $767,231 for the same period in 2024. The decrease in net loss was primarily due to the absence of a $720,000 loss on acquisition of intangible assets incurred in 2024.
- Operating expenses significantly increased to $143,121 for the six months ended June 30, 2025, from $39,755 for the same period in 2024, mainly due to increased wages for the former CEO.
- The company has accumulated deficits of $4,120,024 as of June 30, 2025.
- Total assets remain at $0 as of June 30, 2025, and December 31, 2024.
- Total liabilities increased to $767,764 as of June 30, 2025, from $708,997 as of December 31, 2024.
- The working capital deficit worsened to $767,764 as of June 30, 2025, from $708,997 as of December 31, 2024.
- Cash used in operating activities for the six months ended June 30, 2025, was $155,346, a significant increase from $39,840 used in the same period in 2024.
- The company explicitly states substantial doubt about its ability to continue as a going concern due to cumulative net losses and dependence on external funding.
- Management concluded that disclosure controls and procedures, as well as internal control over financial reporting, were not effective as of June 30, 2025, citing limited internal resources and lack of segregation of duties.
Sentiment
Score: 1
Explanation: The company reports zero revenue, significant and increasing operating losses, and an accumulated deficit of over $4.1 million. It explicitly states substantial doubt about its ability to continue as a going concern, with no firm financing agreements and $0 in total assets. Internal controls are deemed ineffective with material weaknesses. These factors indicate extreme financial distress and high risk for investors.
Positives
- The net loss for the six months ended June 30, 2025, decreased to $154,667 from $767,231 in the prior year, primarily due to the non-recurrence of a $720,000 loss on intangible asset acquisition from 2024.
- The company acquired Artificial Intelligence (AI) assets related to 'Multidoc AI' in May 2024, a system designed for businesses to create AI assistants for document-based query resolution.
- Raised $95,500 in cash from the sale of 9,590,000 common shares during the six months ended June 30, 2025.
Negatives
- Reported zero revenue for the three and six months ended June 30, 2025, and 2024.
- Incurred a net loss of $154,667 for the six months ended June 30, 2025.
- Operating expenses increased significantly to $143,121 for the six months ended June 30, 2025, from $39,755 in the prior year period.
- Accumulated deficit reached $4,120,024 as of June 30, 2025.
- Total assets are $0 as of June 30, 2025.
- Total liabilities increased to $767,764 as of June 30, 2025.
- Working capital deficit worsened to $767,764 as of June 30, 2025.
- Cash used in operating activities increased substantially to $155,346 for the six months ended June 30, 2025.
- The company explicitly states substantial doubt about its ability to continue as a going concern.
- Internal controls over financial reporting were deemed not effective due to limited resources and lack of segregation of duties.
- A promissory note of $7,000 to a related party was due on July 14, 2019, and remains unpaid.
Risks
- Substantial doubt about the company's ability to continue as a going concern due to cumulative net losses and dependence on external funding.
- Inability to attract and receive sufficient funding from the sale of securities, private investment, or strategic partners.
- Potential for substantial dilution to existing stockholders if additional equity financing is obtained.
- Risk of curtailing development plans if necessary financing is not secured.
- Ineffective disclosure controls and procedures and internal control over financial reporting, leading to a reasonable possibility of material misstatement.
- Material weakness in financial reporting due to insufficient dedicated resources, experienced personnel, and lack of segregation of duties.
- Absence of an audit committee or an independent audit committee financial expert, which management views as a control deficiency.
- Uncertainty of outcomes in legal proceedings or claims, which could have a material adverse effect.
- Reliance on the successful development and commercialization of its core products (Multidoc AI) to generate revenue, which has not yet occurred.
Future Outlook
Management expects operating expenses to increase in the future as the company begins to generate more licensing revenue. The company intends to fund operations through increased sales and debt and/or equity financing arrangements, acknowledging these may be insufficient. They plan to seek additional financing through a private equity offering.
Management Comments
- "We expect our operating expenses will increase in the future as the Company begins to generate more licensing revenue."
- "We intend to fund operations through increased sales and debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements."
- "We plan to seek additional financing in a private equity offering to secure funding for operations."
- "We are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner."
Industry Context
Neuralbase AI Ltd. operates in the highly competitive and rapidly evolving Artificial Intelligence (AI) sector, specifically focusing on 'Multidoc AI' for document-based query resolution. The company's current financial state, characterized by zero revenue and significant losses, indicates it is in a very early stage of commercialization, far from establishing a market presence or generating commercial success within the broader AI industry, which includes well-funded and established players like OpenAI, Google, and Microsoft.
Comparison to Industry Standards
- Neuralbase AI's reported zero revenue is significantly below industry standards for publicly traded technology or AI companies, which typically demonstrate revenue generation or a clear path to commercialization.
- Unlike established AI companies that show substantial R&D investment and user adoption, Neuralbase AI provides no metrics on Multidoc AI's market penetration, user base, or commercial viability.
- The company's financial position, including $0 in total assets and a substantial accumulated deficit, is more akin to a pre-revenue startup than a mature public company, contrasting sharply with the robust balance sheets and growth trajectories of successful AI firms.
- The explicit 'going concern' doubt and ineffective internal controls are severe deficiencies not typically seen in healthy, comparable companies in the technology sector.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President, Chief Executive Officer, Treasurer, Chief Financial Officer, and Director | Henry Chang Manayan | Charandeep Gopishetty | March 7, 2023 | Resignation of Mr. Manayan, not due to disagreements. |
| Sole-Officer and Director | Charandeep Gopishetty | Frank Gomez | May 16, 2024 | Resignation of Mr. Gopishetty, not due to disagreements, concurrent with an asset purchase agreement. |
| Chief Executive Officer & Chief Financial Officer | Frank Gomez | Vighnesh Dobale | After June 30, 2025, by August 14, 2025 | Vighnesh Dobale signed the Form 10-Q as CEO & CFO on August 14, 2025, implying a change from Frank Gomez, who was appointed in May 2024 and also signed certifications for the same filing date, indicating an unclear transition or dual role. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Deficiency | Management concluded that disclosure controls and procedures were not effective due to limited internal resources and lack of ability to have multiple levels of transaction review. | June 30, 2025 | Raises risk of material misstatements not being prevented or detected on a timely basis, though management believes financial statements are materially correct. |
| Internal Control Deficiency | A material weakness exists due to an insufficient quantity of dedicated resources and experienced personnel involved in reviewing and designing internal controls. | June 30, 2025 | A material misstatement of the interim and annual financial statements could occur and not be prevented or detected on a timely basis. |
| Internal Control Deficiency | The company has not achieved the optimal level of segregation of duties relative to key financial reporting functions. | June 30, 2025 | Contributes to a material weakness in financial reporting. |
| Internal Control Deficiency | The company does not have an audit committee or an independent audit committee financial expert. | June 30, 2025 | Management views this as an important entity-level control deficiency over the company's financial statements. |
Legal Proceedings
- The company is not party to any material legal proceedings.
- From time to time, the company may be involved in legal proceedings or subject to claims incident to the ordinary course of business, with outcomes inherently uncertain.
Related Party Transactions
- A promissory note amounting to $7,000 was issued to a related party, carrying a 5% interest rate and due on July 14, 2019 (overdue).
- Advances due to related parties total $80,680, bearing no interest and due on demand.
Stakeholder Impact
- Shareholders face significant risk of investment loss due to the company's going concern doubt, zero revenue, and increasing accumulated deficit.
- Shareholders are exposed to substantial dilution risk from anticipated future equity financing.
- Creditors face increased risk due to the company's inability to generate revenue, growing liabilities, and reliance on future financing.
- The seller of the Multidoc AI assets (Frank Gomez or assigns) holds voting control of the company through Series A Preferred Stock, which converts to common stock with 500x voting rights per share.
Next Steps
- Obtain sufficient capital and operations to implement internal controls.
- Assess current duties of existing personnel and consultants, assign additional duties, and potentially hire additional personnel to allow for proper segregation of duties and additional resources for control documentation.
- Assess the duties of existing officers and potentially promote or hire additional personnel to diversify duties and responsibilities.
- Board to review and make recommendations to shareholders concerning the composition of the Board of Directors, with particular focus on issues of independence.
- Consider nominating an audit committee and audit committee financial expert.
- Interview and potentially hire outside consultants that are experts in designing internal controls over financial reporting.
- Fund operations through increased sales and debt and/or equity financing arrangements.
- Seek additional financing in a private equity offering to secure funding for operations.
Key Dates
| Date | Description |
|---|---|
| 2000-03-21 | Company incorporated under the laws of California as Acquisition Solutions. |
| 2006-07-18 | Company became a Nevada corporation. |
| 2019-07-14 | Due date for a $7,000 promissory note payable to a related party. |
| 2023-03-07 | Mr. Henry Chang Manayan resigned as sole officer and director; Mr. Charandeep Gopishetty appointed President, CEO, Treasurer, CFO, and Director. |
| 2024-05-16 | Unwind Agreement and Mutual Release entered to void a previous Purchase Agreement; Asset Purchase Agreement entered with Mr. Frank Gomez and Grupo FG SAS for Multidoc AI assets; Charandeep Gopishetty resigned; Mr. Frank Gomez appointed Sole-Officer and Director. |
| 2025-01-24 | A shareholder converted 1,000,000 shares of Class A Preferred Stock into 50,000,000 shares of Common Stock. |
| 2025-03-31 | End of first fiscal quarter for 2025. |
| 2025-06-30 | End of the quarterly reporting period for this Form 10-Q. |
| 2025-08-14 | Date of filing of the Form 10-Q; date as of which 59,790,183 shares of common stock were issued and outstanding; date of certifications by CEO/CFO. |
| 2052-03-XX | Maturity date for the $46,000 EDIL Loan. |
Recommendation
strong sellThe company reports zero revenue, significant and increasing operating losses, and an accumulated deficit of over $4.1 million. It explicitly states substantial doubt about its ability to continue as a going concern, with no firm financing agreements and $0 in total assets. Internal controls are deemed ineffective with material weaknesses, including a lack of segregation of duties and no audit committee. The company is entirely dependent on future capital raises, which will likely result in significant dilution for existing shareholders. The acquisition of AI assets has not translated into any revenue or operational improvement. These factors indicate extreme financial distress and high risk for investors, making the stock a strong sell.
Keywords
Neuralbase AI, Artificial Intelligence, AI, Multidoc AI, SEC filing, 10-Q, financial report, going concern, corporate governance, financial distress, technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.